AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE

N/A

Manufactured by Wal-Mart Stores Inc

931 FDA adverse event reports analyzed

Last updated: 2026-04-15

About AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE

AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Wal-Mart Stores Inc. The most commonly reported adverse reactions for AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE include DRUG INEFFECTIVE, FATIGUE, RASH, DYSPNOEA, HEADACHE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE.

Top Adverse Reactions

DRUG INEFFECTIVE27 reports
FATIGUE24 reports
RASH24 reports
DYSPNOEA23 reports
HEADACHE22 reports
PRURITUS22 reports
PAIN21 reports
PRODUCT USE ISSUE20 reports
ARTHRALGIA18 reports
ERYTHEMA18 reports
OFF LABEL USE16 reports
DIARRHOEA15 reports
NAUSEA15 reports
ANXIETY14 reports
DEPRESSION14 reports
COUGH13 reports
DIZZINESS13 reports
DRY SKIN13 reports
HYPERSENSITIVITY13 reports
PAIN IN EXTREMITY13 reports
CHRONIC KIDNEY DISEASE12 reports
CONSTIPATION12 reports
APPLICATION SITE ERYTHEMA11 reports
DRUG HYPERSENSITIVITY11 reports
FALL11 reports
WEIGHT DECREASED11 reports
ACNE10 reports
ACUTE KIDNEY INJURY10 reports
CONDITION AGGRAVATED10 reports
HYPERTENSION10 reports
RENAL FAILURE10 reports
SOMNOLENCE10 reports
SUNBURN10 reports
SWELLING FACE10 reports
URTICARIA10 reports
WEIGHT INCREASED10 reports
ABDOMINAL PAIN UPPER9 reports
ASTHENIA9 reports
BLISTER9 reports
EYE IRRITATION9 reports
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION9 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION9 reports
VOMITING9 reports
ABDOMINAL DISCOMFORT8 reports
BLOOD PRESSURE INCREASED8 reports
HEART RATE INCREASED8 reports
INSOMNIA8 reports
INTENTIONAL PRODUCT MISUSE8 reports
MALAISE8 reports
MALIGNANT MELANOMA8 reports
PNEUMONIA8 reports
PSORIASIS8 reports
APPLICATION SITE PAIN7 reports
BACK PAIN7 reports
DERMATITIS7 reports
GASTROOESOPHAGEAL REFLUX DISEASE7 reports
MUSCLE SPASMS7 reports
SKIN EXFOLIATION7 reports
ABDOMINAL PAIN6 reports
ALOPECIA6 reports
BLOOD CHOLESTEROL INCREASED6 reports
BURNING SENSATION6 reports
CHEST PAIN6 reports
COVID 196 reports
DEATH6 reports
DRUG DOSE OMISSION6 reports
ECZEMA6 reports
MUSCULOSKELETAL STIFFNESS6 reports
OVERDOSE6 reports
PRODUCT DOSE OMISSION ISSUE6 reports
PYREXIA6 reports
SKIN BURNING SENSATION6 reports
SKIN LESION6 reports
SWELLING6 reports
THERAPEUTIC RESPONSE UNEXPECTED6 reports
URINARY TRACT INFECTION6 reports
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS6 reports
APPLICATION SITE BURN5 reports
APPLICATION SITE PRURITUS5 reports
BLOOD GLUCOSE INCREASED5 reports
BODY HEIGHT DECREASED5 reports
DECREASED APPETITE5 reports
DRY EYE5 reports
DRY MOUTH5 reports
GAIT DISTURBANCE5 reports
ILLNESS5 reports
INCORRECT DOSE ADMINISTERED5 reports
INCORRECT DRUG ADMINISTRATION DURATION5 reports
MUSCULAR WEAKNESS5 reports
NASOPHARYNGITIS5 reports
PHOTOSENSITIVITY REACTION5 reports
PRODUCT QUALITY ISSUE5 reports
RASH ERYTHEMATOUS5 reports
SKIN HYPERPIGMENTATION5 reports
SKIN IRRITATION5 reports
SUICIDAL IDEATION5 reports
THERAPY CESSATION5 reports
VISION BLURRED5 reports
XEROSIS5 reports
ABDOMINAL DISTENSION4 reports

Report Outcomes

Out of 441 classified reports for AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE:

Serious 47.4%Non-Serious 52.6%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female266 (65.4%)
Male141 (34.6%)

Reports by Age

Age 5813 reports
Age 6211 reports
Age 579 reports
Age 699 reports
Age 729 reports
Age 769 reports
Age 658 reports
Age 668 reports
Age 708 reports
Age 407 reports
Age 447 reports
Age 547 reports
Age 757 reports
Age 807 reports
Age 506 reports
Age 596 reports
Age 606 reports
Age 816 reports
Age 475 reports
Age 685 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE?

This profile reflects 931 FDA FAERS reports that mention AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE?

Frequently reported terms in FAERS include DRUG INEFFECTIVE, FATIGUE, RASH, DYSPNOEA, HEADACHE, PRURITUS. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE?

Labeling and FAERS entries often list Wal-Mart Stores Inc in connection with AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.